World News

RH stock slips following earnings, outlook

Verint to split in two publicly traded companies; stock halted

Verint Systems Inc. VRNT, +0.53% late Wednesday said its board has approved a plan to split the company in two separate publicly traded companies, one focusing on its consumer engagement business and the other on cyber intelligence. The separation is expected to be complete "shortly after" the end of Verint’s fiscal year in January 2021, Verint said. "With our customer engagement business approaching $1 billion in annual revenue and our cyber intelligence business approaching $500 million in annual revenue, we believe the two independent, publicly traded companies will both benefit from the separation and be well positioned to pursue their own strategies, drive opportunities to accelerate growth and extend their market leadership," Verint Chief Executive Dan Bodner said in a statement. Shares of Verint were halted ahead of the announcement, and ended the regular trading day up 0.5%.

Major US airlines crippled by Google tech problem

A view inside John F. Kennedy International Airport at the Delta Airlines gate on a typical morning with passengers in view.

The websites of three major U.S. airlines experienced a brief technical issue Wednesday afternoon.

Continue Reading Below

American, Delta and United airlines all issued notices on their sites of an issue affecting flight booking.

American said the glitch was a result of a “brief” Google technical issue.

“Earlier today, Google had a brief technical issue that impacted multiple carriers, including American. This technical issue has been resolved. We apologize to our customers for the inconvenience. There was no impact to flight operations.”

Delta and United did not immediately respond to FOX Business’ request for comment. Google did not respond to a request for comment at the time of publication.

UN Ambassador Kelly Knight Craft Is Hosting An ‘End Of Presidency’ Party

The U.S. ambassador to the United Nations, Kelly Knight Craft, may have to do some explaining to President Donald Trump ― but it’s all just a big misunderstanding.

On Wednesday, Axios reporter Jonathan Swan tweeted a photo of a save-the-date card sent out by Craft for something called an “End of Presidency and Holiday Reception.”

Considering the impeachment investigation has been fairly damning to Trump, some people wondered if Craft was onto something. The Dec. 20 date for the party is right around the time the House might be voting on whether to impeach the president.

One person thought she had a good idea on how Trump should respond.

Others thought Trump would be angered by the name of the reception, but not the “End of Presidency” part.

But CNBC journalist Christina Wilkie was quick to (depending on your point of view) provide needed clarity or ruin the fun for snarky Twitter wits.

She said the “End of Presidency” bit refers to “the monthly rotation of the presidency of the UN Security Council, which the US holds this month.”

Anna Faris saved from carbon monoxide poisoning

Anna Faris is expressing her “gratitude” to the North Lake Tahoe fire department after dealing with a carbon monoxide scare over the weekend.

Faris and her family were in Lake Tahoe at a rental house over the U.S. Thanksgiving holiday when two people fell ill to what they thought was altitude sickness.

Aurinia Pharmaceuticals surges more than 110%, after positive trial for lupus-related drug

Aurinia Pharmaceuticals Inc. AUPH, +5.14%AUP, +4.90% stock rampaged in the extended session, rising more than 110% after the company announced positive efficacy and safety results from a Phase 3 trial for a drug that treats a common complication of lupus, an autoimmune disease. The complication known as lupus nephritis is a frequent complication of the disease commonly known as lupus. "This extraordinary pivotal data confirms voclosporin’s ability to achieve statistically significant improvements in clinically meaningful endpoints for this complex disease, with a comparable safety profile to the current standard of care," Chief Medical Officer Neil Solomons said in a statement. "This data represents a significant advance for people living with LN, which can lead to irreversible kidney damage, eventual kidney failure and death." The company’s drug is called voclosporin, and Aurinia said it expects that if it achieves regulatory approval then patent protection for the drug will be extended in the U.S. and Europe, among other markets, until 2027. Aurinia Pharmaceuticals is headquartered in Victoria, British Columbia and trades on the Toronto Stock Exchange and the Nasdaq. Prior to Wednesday’s after-hours stock move, Aurinia stock had gained 23% this year, as the S&P 500 index SPX, +0.63% also rose 23%.

RH stock slips following earnings, outlook

RH RH, +2.86% shares slipped in the extended session Wednesday after the company formerly known as Restoration Hardware topped earnings estimates for the previous quarter but left estimates for the current one essentially unchanged. RH shares declined 1.5% after hours, following a 2.9% rise in the regular session to close at $205.62. The company reported third-quarter net income of $52.5 million, or $2.17 a share, compared with $20.1 million, or 73 cents a share, in the year-ago period. Adjusted earnings were $2.79 a share. Revenue rose to $677.5 million from $636.6 million in the year-ago quarter. Analysts surveyed by FactSet had forecast earnings of $2.23 on revenue of $676.4 million. RH expects earnings of $3.50 to $3.62 a share on revenue of $703 million to $711.5 million, while analysts had forecast earnings of $3.58 a share on revenue of $709.5 million.